Compare OLED & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OLED | BIO |
|---|---|---|
| Founded | 1985 | 1952 |
| Country | United States | United States |
| Employees | N/A | 7450 |
| Industry | Semiconductors | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 7.1B |
| IPO Year | 1996 | N/A |
| Metric | OLED | BIO |
|---|---|---|
| Price | $98.65 | $295.94 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 4 |
| Target Price | $125.00 | ★ $339.75 |
| AVG Volume (30 Days) | ★ 601.6K | 274.0K |
| Earning Date | 04-30-2026 | 04-30-2026 |
| Dividend Yield | ★ 2.06% | N/A |
| EPS Growth | ★ 9.25 | N/A |
| EPS | ★ 5.08 | N/A |
| Revenue | ★ $650,611,000.00 | N/A |
| Revenue This Year | $6.21 | $2.59 |
| Revenue Next Year | $10.25 | $3.21 |
| P/E Ratio | $19.11 | ★ $9.72 |
| Revenue Growth | ★ 0.45 | N/A |
| 52 Week Low | $86.43 | $211.43 |
| 52 Week High | $163.20 | $343.12 |
| Indicator | OLED | BIO |
|---|---|---|
| Relative Strength Index (RSI) | 53.73 | 66.68 |
| Support Level | $93.03 | $293.88 |
| Resistance Level | $107.90 | $311.09 |
| Average True Range (ATR) | 3.25 | 7.45 |
| MACD | 1.55 | 2.63 |
| Stochastic Oscillator | 83.68 | 93.87 |
Universal Display Corp researches, develops, and manufactures organic light-emitting diode, or OLED, technologies for use in displays for mobile phones, tablets, televisions, wearables, personal computers, automotive interiors, and the solid-state lighting market. OLED technologies are an alternative to light-emitting diode, or LED, technologies, in the solid-state lighting market, and liquid crystal displays in the flat-panel-display market. The Company has one reportable business segment being OLED technologies and materials. A large majority of the firm's revenue is generated in South Korea, with the rest coming from Japan, China, the United States, and other countries across the world.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.